pathdoc / Shutterstock.com
Pharmaceutical company Teva and US-based Antares Pharma have launched a generic version of Imitrex (sumatriptan succinate), which is used to treat migraines.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, Antares Pharma, Imitrex, sumatriptan succinate, American Migraine Study, cluster headaches, migraines, Siggi Olafsson, Robert Apple,